Bioelectrical impedance analysis-derived phase angle (PhA) in lung cancer patients: a systematic review.
Body composition
Lung cancer
Phase angle
Journal
BMC cancer
ISSN: 1471-2407
Titre abrégé: BMC Cancer
Pays: England
ID NLM: 100967800
Informations de publication
Date de publication:
20 May 2024
20 May 2024
Historique:
received:
21
12
2023
accepted:
13
05
2024
medline:
21
5
2024
pubmed:
21
5
2024
entrez:
20
5
2024
Statut:
epublish
Résumé
Lung cancer is the second most diagnosed cancer in the world. Up to 84% of diagnosed patients have malnutrition, which can negatively affect quality of life and survival and may worsen with neoadjuvant treatment. Bioelectrical Impedance Analysis-Derived Phase Angle (PhA) in these patients could be a valid tool to assess the nutritional status in order to improve their condition. This review provides an update on PhA assessment in lung cancer patients over the past twenty years. We searched PubMed, Embase, Scopus, Web of Science, and Cochrane, for articles regarding the PhA obtained from Bioelectrical Impedance Analysis in lung cancer patients. The authors independently performed a literature search: sample size, patient population, study type, study dates, survival and interventions were evaluated. The final review included 11 studies from different countries. Eight studies only considered patients with lung cancer, while three studies considered patients with different kind of cancer, including lung. Correlation data between PhA and age are conflicting. In patients undergoing clinical treatment and patients undergoing surgical treatment lower PhA was observed. A lower PhA is associated with a shorter survival. In three studies emerged a relationship between Karnofski Performance Status and Handgrip Strenght with PhA. From one study, univariate logistic regression analysis showed that higher PhA values represent a protective factor for sarcopenia. Our research underlined interesting, but not conclusive, results on this topic; however more researches are needed to understand the clinical meaning of PhA.
Sections du résumé
BACKGROUND
BACKGROUND
Lung cancer is the second most diagnosed cancer in the world. Up to 84% of diagnosed patients have malnutrition, which can negatively affect quality of life and survival and may worsen with neoadjuvant treatment. Bioelectrical Impedance Analysis-Derived Phase Angle (PhA) in these patients could be a valid tool to assess the nutritional status in order to improve their condition.
METHODS
METHODS
This review provides an update on PhA assessment in lung cancer patients over the past twenty years. We searched PubMed, Embase, Scopus, Web of Science, and Cochrane, for articles regarding the PhA obtained from Bioelectrical Impedance Analysis in lung cancer patients. The authors independently performed a literature search: sample size, patient population, study type, study dates, survival and interventions were evaluated. The final review included 11 studies from different countries.
RESULTS
RESULTS
Eight studies only considered patients with lung cancer, while three studies considered patients with different kind of cancer, including lung. Correlation data between PhA and age are conflicting. In patients undergoing clinical treatment and patients undergoing surgical treatment lower PhA was observed. A lower PhA is associated with a shorter survival. In three studies emerged a relationship between Karnofski Performance Status and Handgrip Strenght with PhA. From one study, univariate logistic regression analysis showed that higher PhA values represent a protective factor for sarcopenia.
CONCLUSION
CONCLUSIONS
Our research underlined interesting, but not conclusive, results on this topic; however more researches are needed to understand the clinical meaning of PhA.
Identifiants
pubmed: 38769506
doi: 10.1186/s12885-024-12378-4
pii: 10.1186/s12885-024-12378-4
doi:
Types de publication
Journal Article
Systematic Review
Langues
eng
Sous-ensembles de citation
IM
Pagination
608Informations de copyright
© 2024. The Author(s).
Références
Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, Bray F. Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. CA Cancer J Clin. 2021;71(3):209–49.
doi: 10.3322/caac.21660
pubmed: 33538338
I Numeri del Cancro in Italia 2022 [ https://www.aiom.it/i-numeri-del-cancro-in-italia/ ].
Zhang P, Chen PL, Li ZH, Zhang A, Zhang XR, Zhang YJ, Liu D, Mao C. Association of smoking and polygenic risk with the incidence of lung cancer: a prospective cohort study. Br J Cancer. 2022;126(11):1637–46.
pubmed: 35194190
pmcid: 9130319
doi: 10.1038/s41416-022-01736-3
Kim CH, Lee YC, Hung RJ, McNallan SR, Cote ML, Lim WY, Chang SC, Kim JH, Ugolini D, Chen Y, et al. Exposure to secondhand tobacco smoke and lung cancer by histological type: a pooled analysis of the International Lung Cancer Consortium (ILCCO). Int J Cancer. 2014;135(8):1918–30.
pubmed: 24615328
pmcid: 4126868
doi: 10.1002/ijc.28835
Luo J, Hendryx M, Ducatman A. Association between six environmental chemicals and lung cancer incidence in the United States. J Environ Public Health. 2011;2011: 463701.
pubmed: 21776439
pmcid: 3136160
doi: 10.1155/2011/463701
Zheng M. Classification and Pathology of Lung Cancer. Surg Oncol Clin N Am. 2016;25(3):447–68.
pubmed: 27261908
doi: 10.1016/j.soc.2016.02.003
Mele MC, Rinninella E, Cintoni M, Pulcini G, Di Donato A, Grassi F, Trestini I, Pozzo C, Tortora G, Gasbarrini A, et al. Nutritional support in lung cancer patients: the state of the art. Clin Lung Cancer. 2021;22(4):e584–94.
pubmed: 33303399
doi: 10.1016/j.cllc.2020.10.008
Beckles MA, Spiro SG, Colice GL, Rudd RM. Initial evaluation of the patient with lung cancer: symptoms, signs, laboratory tests, and paraneoplastic syndromes. Chest. 2003;123(1 Suppl):97S–104S.
pubmed: 12527569
doi: 10.1378/chest.123.1_suppl.97S
Polanski J, Jankowska-Polanska B, Rosinczuk J, Chabowski M, Szymanska-Chabowska A. Quality of life of patients with lung cancer. Onco Targets Ther. 2016;9:1023–8.
pubmed: 27013895
pmcid: 4778772
Arends J, Baracos V, Bertz H, Bozzetti F, Calder PC, Deutz NEP, Erickson N, Laviano A, Lisanti MP, Lobo DN, et al. ESPEN expert group recommendations for action against cancer-related malnutrition. Clin Nutr. 2017;36(5):1187–96.
pubmed: 28689670
doi: 10.1016/j.clnu.2017.06.017
Porro C, La Torre ME, Tartaglia N, Benameur T, Santini M, Ambrosi A, Messina G, Cibelli G, Fiorelli A, Polito R, et al. The potential role of nutrition in lung cancer establishment and progression. Life (Basel). 2022;12(2):270.
pubmed: 35207557
Pilikidou M, Palyvou F, Papadopoulou SK, Tsiouda T, Tsekitsidi E, Arvaniti K, Miziou A, Tsingerlioti Z, Apostolidis G, Ntiloudis R, et al. Lung cancer, treatment and nutritional status. Mol Clin Oncol. 2021;15(6):248.
pubmed: 34671467
pmcid: 8521381
doi: 10.3892/mco.2021.2410
Dewys WD, Begg C, Lavin PT, Band PR, Bennett JM, Bertino JR, Cohen MH, Douglass HO, Jr., Engstrom PF, Ezdinli EZ et al.: Prognostic effect of weight loss prior to chemotherapy in cancer patients. Eastern Cooperative Oncology Group. Am J Med 1980, 69(4):491–497.
pubmed: 7424938
doi: 10.1016/S0149-2918(05)80001-3
Ravasco P, Monteiro-Grillo I, Vidal PM, Camilo ME. Nutritional deterioration in cancer: the role of disease and diet. Clin Oncol (R Coll Radiol). 2003;15(8):443–50.
pubmed: 14689999
doi: 10.1016/S0936-6555(03)00155-9
Prado CM, Lieffers JR, Bowthorpe L, Baracos VE, Mourtzakis M, McCargar LJ. Sarcopenia and physical function in overweight patients with advanced cancer. Can J Diet Pract Res. 2013;74(2):69–74.
pubmed: 23750978
doi: 10.3148/74.2.2013.69
Fortunati N, Manti R, Birocco N, Pugliese M, Brignardello E, Ciuffreda L, Catalano MG, Aragno M, Boccuzzi G. Pro-inflammatory cytokines and oxidative stress/antioxidant parameters characterize the bio-humoral profile of early cachexia in lung cancer patients. Oncol Rep. 2007;18(6):1521–7.
pubmed: 17982639
Duguet A, Bachmann P, Lallemand Y, Blanc-Vincent MP. Good clinical practice in nutritional management in cancer patients: malnutrition and nutritional assessment. Bull Cancer. 1999;86(12):997–1016.
pubmed: 10660694
Polanski J, Chabowski M, Swiatoniowska-Lonc N, Dudek K, Jankowska-Polanska B, Zabierowski J, Mazur G: Relationship between Nutritional Status and Clinical Outcome in Patients Treated for Lung Cancer. Nutrients 2021;13(10):3332.
pubmed: 34684333
pmcid: 8539241
doi: 10.3390/nu13103332
Lin TY, Chen YF, Wu WT, Han DS, Tsai IC, Chang KV, Ozcakar L. Impact of sarcopenia on the prognosis and treatment of lung cancer: an umbrella review. Discov Oncol. 2022;13(1):115.
pubmed: 36307591
pmcid: 9616989
doi: 10.1007/s12672-022-00576-0
Bapuji SB, Sawatzky JA. Understanding weight loss in patients with colorectal cancer: a human response to illness. Oncol Nurs Forum. 2010;37(3):303–10.
pubmed: 20439214
doi: 10.1188/10.ONF.303-310
Argiles JM, Lopez-Soriano FJ, Busquets S. Mechanisms and treatment of cancer cachexia. Nutr Metab Cardiovasc Dis. 2013;23(Suppl 1):S19–24.
pubmed: 22749678
doi: 10.1016/j.numecd.2012.04.011
Wang J, Tan S, Gianotti L, Wu G. Evaluation and management of body composition changes in cancer patients. Nutrition. 2023;114:112132.
pubmed: 37441827
doi: 10.1016/j.nut.2023.112132
Yamada Y, Buehring B, Krueger D, Anderson RM, Schoeller DA, Binkley N. Electrical Properties Assessed by Bioelectrical Impedance Spectroscopy as Biomarkers of Age-related Loss of Skeletal Muscle Quantity and Quality. J Gerontol A Biol Sci Med Sci. 2017;72(9):1180–6.
pubmed: 28814064
Barbosa-Silva MC, Barros AJ. Bioelectrical impedance analysis in clinical practice: a new perspective on its use beyond body composition equations. Curr Opin Clin Nutr Metab Care. 2005;8(3):311–7.
pubmed: 15809535
doi: 10.1097/01.mco.0000165011.69943.39
Almada-Correia I, Neves PM, Makitie A, Ravasco P. Body Composition Evaluation in Head and Neck Cancer Patients: A Review. Front Oncol. 2019;9:1112.
pubmed: 31788443
pmcid: 6854012
doi: 10.3389/fonc.2019.01112
Branco MG, Mateus C, Capelas ML, Pimenta N, Santos T, Makitie A, Ganhao-Arranhado S, Trabulo C, Ravasco P: Bioelectrical Impedance Analysis (BIA) for the Assessment of Body Composition in Oncology: A Scoping Review. Nutrients 2023, 15(22):792.
doi: 10.3390/nu15224792
Caccialanza R, Cotogni P, Cereda E, Bossi P, Aprile G, Delrio P, Gnagnarella P, Mascheroni A, Monge T, Corradi E, et al. Nutritional support in cancer patients: update of the Italian Intersociety Working Group practical recommendations. J Cancer. 2022;13(9):2705–16.
pubmed: 35812181
pmcid: 9254882
doi: 10.7150/jca.73130
Shintani Y, Ikeda N, Matsumoto T, Kadota Y, Okumura M, Ohno Y, Ohta M. Nutritional status of patients undergoing chemoradiotherapy for lung cancer. Asian Cardiovasc Thorac Ann. 2012;20(2):172–6.
pubmed: 22499965
doi: 10.1177/0218492311435249
Marin Caro MM, Laviano A, Pichard C. Nutritional intervention and quality of life in adult oncology patients. Clin Nutr. 2007;26(3):289–301.
pubmed: 17368656
doi: 10.1016/j.clnu.2007.01.005
Gupta D, Lis CG, Dahlk SL, Vashi PG, Grutsch JF, Lammersfeld CA. Bioelectrical impedance phase angle as a prognostic indicator in advanced pancreatic cancer. Br J Nutr. 2004;92(6):957–62.
pubmed: 15613258
doi: 10.1079/BJN20041292
Gupta D, Lammersfeld CA, Vashi PG, King J, Dahlk SL, Grutsch JF, Lis CG. Bioelectrical impedance phase angle as a prognostic indicator in breast cancer. BMC Cancer. 2008;8:249.
pubmed: 18727837
pmcid: 2527613
doi: 10.1186/1471-2407-8-249
Gupta D, Lammersfeld CA, Burrows JL, Dahlk SL, Vashi PG, Grutsch JF, Hoffman S, Lis CG. Bioelectrical impedance phase angle in clinical practice: implications for prognosis in advanced colorectal cancer. Am J Clin Nutr. 2004;80(6):1634–8.
pubmed: 15585779
doi: 10.1093/ajcn/80.6.1634
Grundmann O, Yoon SL, Williams JJ. The value of bioelectrical impedance analysis and phase angle in the evaluation of malnutrition and quality of life in cancer patients–a comprehensive review. Eur J Clin Nutr. 2015;69(12):1290–7.
pubmed: 26220573
doi: 10.1038/ejcn.2015.126
Gupta D, Lammersfeld CA, Vashi PG, King J, Dahlk SL, Grutsch JF, Lis CG. Bioelectrical impedance phase angle in clinical practice: implications for prognosis in stage IIIB and IV non-small cell lung cancer. BMC Cancer. 2009;9:37.
pubmed: 19175932
pmcid: 2637288
doi: 10.1186/1471-2407-9-37
Hui D, Bansal S, Morgado M, Dev R, Chisholm G, Bruera E. Phase angle for prognostication of survival in patients with advanced cancer: preliminary findings. Cancer. 2014;120(14):2207–14.
pubmed: 24899148
doi: 10.1002/cncr.28624
Ji W, Liu X, Zheng K, Yang H, Cui J, Li W. Correlation of phase angle with sarcopenia and its diagnostic value in elderly men with cancer. Nutrition. 2021;84:111110.
pubmed: 33453619
doi: 10.1016/j.nut.2020.111110
Navigante A, Morgado PC, Casbarien O, Delgado NL, Giglio R, Perman M. Relationship between weakness and phase angle in advanced cancer patients with fatigue. Support Care Cancer. 2013;21(6):1685–90.
pubmed: 23321933
doi: 10.1007/s00520-012-1714-2
Sanchez-Lara K, Turcott JG, Juarez E, Guevara P, Nunez-Valencia C, Onate-Ocana LF, Flores D, Arrieta O. Association of nutrition parameters including bioelectrical impedance and systemic inflammatory response with quality of life and prognosis in patients with advanced non-small-cell lung cancer: a prospective study. Nutr Cancer. 2012;64(4):526–34.
pubmed: 22489794
doi: 10.1080/01635581.2012.668744
Shi J, Xie H, Ruan G, Ge Y, Lin S, Zhang H, Zheng X, Liu C, Song M, Liu T, et al. Sex differences in the association of phase angle and lung cancer mortality. Front Nutr. 2022;9:1061996.
pubmed: 36618681
pmcid: 9818340
doi: 10.3389/fnut.2022.1061996
Detopoulou P, Tsiouda T, Pilikidou M, Palyvou F, Mantzorou M, Perzirkianidou P, Kyrka K, Methenitis S, Kondyli FS, Voulgaridou G, et al. Dietary habits are related to phase angle in male patients with non-small-cell lung cancer. Curr Oncol. 2022;29(11):8074–83.
pubmed: 36354697
pmcid: 9689548
doi: 10.3390/curroncol29110637
Detopoulou P, Tsiouda T, Pilikidou M, Palyvou F, Tsekitsidi E, Mantzorou M, Pezirkianidou P, Kyrka K, Methenitis S, Voulgaridou G et al: Changes in Body Weight, Body Composition, Phase Angle, and Resting Metabolic Rate in Male Patients with Stage IV Non-Small-Cell Lung Cancer Undergoing Therapy. Medicina (Kaunas) 2022;58(12):1779.
pubmed: 36556981
doi: 10.3390/medicina58121779
Toso S, Piccoli A, Gusella M, Menon D, Bononi A, Crepaldi G, Ferrazzi E. Altered tissue electric properties in lung cancer patients as detected by bioelectric impedance vector analysis. Nutrition. 2000;16(2):120–4.
pubmed: 10696635
doi: 10.1016/S0899-9007(99)00230-0
Suzuki Y, Kushimoto Y, Ishizawa H, Kawai H, Ito A, Matsuda Y, Hoshikawa Y. The phase angle as a predictor of postoperative complications in patients undergoing lung cancer surgery. Surg Today. 2023;53(3):332–7.
pubmed: 35904605
doi: 10.1007/s00595-022-02564-x
Castanho IA, Lopes AJ, Koury JC, Tessarollo B, Silva AC, Nunes RA. Relationship between the phase angle and volume of tumours in patients with lung cancer. Ann Nutr Metab. 2013;62(1):68–74.
pubmed: 23257390
doi: 10.1159/000345588
Hui D, Moore J, Park M, Liu D, Bruera E. Phase Angle and the Diagnosis of Impending Death in Patients with Advanced Cancer: Preliminary Findings. Oncologist. 2019;24(6):e365–73.
pubmed: 30352942
doi: 10.1634/theoncologist.2018-0288
De Benedetto F, Marinari S, De Blasio F. Phase angle in assessment and monitoring treatment of individuals with respiratory disease. Rev Endocr Metab Disord. 2023;24(3):491–502.
pubmed: 36694055
doi: 10.1007/s11154-023-09786-5
Amano K, Bruera E, Hui D. Diagnostic and prognostic utility of phase angle in patients with cancer. Rev Endocr Metab Disord. 2023;24(3):479–89.
pubmed: 36484944
doi: 10.1007/s11154-022-09776-z
Naughton MJ, Weaver KE. Physical and mental health among cancer survivors: considerations for long-term care and quality of life. N C Med J. 2014;75(4):283–6.
pubmed: 25046097
pmcid: 4503227
Uccella S, Mele MC, Quagliozzi L, Rinninella E, Nero C, Cappuccio S, Cintoni M, Gasbarrini A, Scambia G, Fagotti A. Assessment of preoperative nutritional status using BIA-derived phase angle (PhA) in patients with advanced ovarian cancer: Correlation with the extent of cytoreduction and complications. Gynecol Oncol. 2018;149(2):263–9.
pubmed: 29550182
doi: 10.1016/j.ygyno.2018.03.044
Inci MG, Richter R, Woopen H, Rasch J, Heise K, Anders L, Mueller K, Nasser S, Siepmann T, Sehouli J. Role of predictive markers for severe postoperative complications in gynecological cancer surgery: a prospective study (RISC-Gyn Trial). Int J Gynecol Cancer. 2020;30(12):1975–82.
pubmed: 33246921
doi: 10.1136/ijgc-2020-001879
Bosy-Westphal A, Danielzik S, Dorhofer RP, Later W, Wiese S, Muller MJ. Phase angle from bioelectrical impedance analysis: population reference values by age, sex, and body mass index. JPEN J Parenter Enteral Nutr. 2006;30(4):309–16.
pubmed: 16804128
doi: 10.1177/0148607106030004309
Norman K, Stobaus N, Pirlich M, Bosy-Westphal A. Bioelectrical phase angle and impedance vector analysis–clinical relevance and applicability of impedance parameters. Clin Nutr. 2012;31(6):854–61.
pubmed: 22698802
doi: 10.1016/j.clnu.2012.05.008
Hodgev VA, Kostianev SS. Maximal inspiratory pressure predicts mortality in patients with chronic obstructive pulmonary disease in a five-year follow-up. Folia Med (Plovdiv). 2006;48(3–4):36–41.
pubmed: 17668695
Cooper R, Kuh D, Hardy R, Mortality Review G. Falcon, Teams HAS: Objectively measured physical capability levels and mortality: systematic review and meta-analysis. BMJ. 2010;341: c4467.
pubmed: 20829298
pmcid: 2938886
doi: 10.1136/bmj.c4467
Sacco AM, Valerio G, Alicante P, Di Gregorio A, Spera R, Ballarin G, Scalfi L. Raw bioelectrical impedance analysis variables (phase angle and impedance ratio) are significant predictors of hand grip strength in adolescents and young adults. Nutrition. 2021;91–92: 111445.
Perez Camargo DA, Allende Perez SR, Verastegui Aviles E, Rivera Franco MM, Meneses Garcia A, Herrera Gomez A, Urbalejo Ceniceros VI. Assessment and impact of phase angle and sarcopenia in palliative cancer patients. Nutr Cancer. 2017;69(8):1227–33.
pubmed: 29083245
doi: 10.1080/01635581.2017.1367939
Detopoulou P, Voulgaridou G, Papadopoulou S. Cancer, Phase Angle and Sarcopenia: The Role of Diet in Connection with Lung Cancer Prognosis. Lung. 2022;200(3):347–79.
pubmed: 35616720
doi: 10.1007/s00408-022-00536-z
Bellido D, Garcia-Garcia C, Talluri A, Lukaski HC, Garcia-Almeida JM. Future lines of research on phase angle: Strengths and limitations. Rev Endocr Metab Disord. 2023;24(3):563–83.
pubmed: 37043140
pmcid: 10090740
doi: 10.1007/s11154-023-09803-7
Blauwhoff-Buskermolen S, Versteeg KS, de van der Schueren MA, den Braver NR, Berkhof J, Langius JA, Verheul HM. Loss of Muscle Mass During Chemotherapy Is Predictive for Poor Survival of Patients With Metastatic Colorectal Cancer. J Clin Oncol 2016;34(12):1339-1344.
Aapro M, Arends J, Bozzetti F, Fearon K, Grunberg SM, Herrstedt J, Hopkinson J, Jacquelin-Ravel N, Jatoi A, Kaasa S, et al. Early recognition of malnutrition and cachexia in the cancer patient: a position paper of a European School of Oncology Task Force. Ann Oncol. 2014;25(8):1492–9.
pubmed: 24569913
doi: 10.1093/annonc/mdu085
Caillet P, Liuu E, Raynaud Simon A, Bonnefoy M, Guerin O, Berrut G, Lesourd B, Jeandel C, Ferry M, Rolland Y, et al. Association between cachexia, chemotherapy and outcomes in older cancer patients: A systematic review. Clin Nutr. 2017;36(6):1473–82.
pubmed: 28017447
doi: 10.1016/j.clnu.2016.12.003